|
|
Protease Inhibitors Safe, Effective in Antiretroviral-Experienced HIV-Infected Children
|
| Link ID |
6542 |
| Title |
Protease Inhibitors Safe, Effective in Antiretroviral-Experienced HIV-Infected Children |
| Url |
http://www.medscape.com/viewarticle/575762?src=rss |
| Description |
Treatment with the protease inhibitors (PI) ritonavir, nelfinavir, and lopinavir/ritonavir is safe and effective for the long-term treatment of antiretroviral-experienced HIV-infected children, according to a report in the May issue of The Pediatric Infectious Disease Journal. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Jun 11, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
New HIV Drug Stalls Infection in Trial
|
|
|
A new kind of experimental HIV medicine can halt one of the earliest stages of HIV infection and may lead in future to a novel class of drugs to fight other dangerous viruses, German scientists said on Wednesday. Reuters Health Information
|
| 4. |
Periodontal Disease May Fuel Reactivation of Latent HIV
|
|
|
Periodontal disease may be a risk factor for reactivation of latent HIV infection and might contribute to the systemic dissemination of the virus causing clinical progression of AIDS, according to research reported today at the 87th General Session of the International Association for Dental Research underway in Miami Beach, Florida. Reuters Health Information
|
|
|
